Investment Summary

SHS Invests In CRYSTAL

On January 1, 2002, private equity firm SHS invested in chemicals company CRYSTAL

Investment Highlights
  • This is SHS’s 1st transaction in the Chemicals sector.
  • This is SHS’s 1st transaction in Germany.
Investment Fate
  • CRYSTAL was sold to a consortium of financial buyers in 2021.

Investment Summary

Date 2002-01-01
Target CRYSTAL
Sector Chemicals
Investor(s) SHS
Deal Type Growth Capital

Target

CRYSTAL

Berlin, Germany
website
CRYSTAL provides advanced products and technologies with crystals and their applications. With sophisticated manufacturing technologies and comprehensive measurement and testing capabilities, the company has guaranteed a high-quality range of substrates/wafers for thin-film deposition and optical components for industrial measurement and laser technology. CRYSTAL was founded in 1990 and is based in Berlin, Germany.

Search 177,729 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor
DESCRIPTION

SHS is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €30 million in businesses valued up to €100 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS was established in 1993 and is headquartered in Tubingen, Germany.


DEAL STATS #
Overall 1 of 26
Sector (Chemicals) 1 of 1
Type (Growth Capital) 1 of 15
Country (Germany) 1 of 17
Year (2002) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2003-01-01 LipoNova AG

Hanover, Germany

LipoNova AG provides therapeutic vaccines against various types of cancer.

Buy -